Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9989724 | Neurobiology of Disease | 2005 | 12 Pages |
Abstract
Repair of myelin damage in the adult CNS requires oligodendrocyte progenitor (OP) proliferation and subsequent differentiation into remyelinating oligodendrocytes. Platelet-derived growth factor (PDGF) and fibroblast growth factor-2 (FGF2) have been predicted to act individually and/or cooperatively to generate remyelinating oligodendrocytes. Analysis of PDGF alpha receptor (PDGFαR) heterozygous (+/â) mice indicates that PDGFαR expression modulates oligodendrocyte density in non-lesioned adult CNS. Analysis of cuprizone demyelination and recovery in PDGFαR+/â mice, FGF2 knockout (â/â) mice, and PDGFαR+/â FGF2â/â mice demonstrated that:( 1) OP proliferation and oligodendrocyte regeneration is impaired in PDGFαR heterozygotes, (2) PDGFαR+/â and FGF2â/â deletions do not act cooperatively to impair OP amplification, (3) oligodendrocyte differentiation is more frequent in FGF2â/â mice, and (4) FGF2 deletion in combination with the PDGFαR+/â genotype rescues impaired oligodendrocyte regeneration of PDGFαR heterozygotes. These findings demonstrate distinct roles for PDGF and FGF2 in vivo in the context of a demyelinating disease with spontaneous remyelination.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Joshua C. Murtie, Yong-Xing Zhou, Tuan Q. Le, Adam C. Vana, Regina C. Armstrong,